市場調査レポート

商品コード

1679358

感染症分子診断の市場規模、シェア、動向分析レポート：製品別、技術別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日: 2025年02月28日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF (Single User License)

USD 5,950 854,241円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 997,811円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,284,951円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

感染症分子診断市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の感染症分子診断市場規模は、2025～2030年にかけてCAGR 3.37％を記録し、2030年までに201億5,000万米ドルに達すると予測されています。

この市場を牽引しているのは、技術的に先進的な製品の導入と、PoC環境における分子診断薬需要の増加です。

携帯性、正確な結果、費用対効果などの急速な技術進歩が、感染症分子診断薬市場の重要な促進要因になると予測されています。企業は、具体的で正確な結果を得るために、新しい技術を導入して製品をアップグレードしています。主要企業は、新興感染症を対象とした新規キットの開発や、他のキット製造企業との契約締結による研究開発イニシアチブの強化により、PCR装置の製品ポートフォリオを更新しています。

INAAT、質量分析、ISHなどの技術は先進的であり、他の伝統的診断検査と比べて偽陽性率が低いです。この技術の費用対効果や使いやすさ、提供される精度などの利点が、この技術の採用を増加させると推定されます。

研究機関における分子診断の使用は増加しています。PCR、ウェスタンブロッティング、サザンブロッティングなどの技術の使用が一般的になりつつあります。さらに、SARS-CoV-2感染の世界の拡大により、革新的な分子診断法を探すために、診断企業だけでなく政府による研究資金も増加しています。

分子診断法は効果的で正確な結果をもたらします。さらに、これらの検査は病気の早期発見を可能にし、代替品の脅威を低く保つ。しかし、これらの検査は高価格であるため、患者は外部の代替品に移行することが予想されます。さらに、SARS-CoV-2のような新しい感染症の検出では、内部代替の割合が高く、競争企業間の敵対関係を後押ししています。

感染症分子診断市場レポートハイライト

2024年の収益シェアは試薬が25.86%で市場をリード、感染症診断に広く使用されているため、予測期間中のCAGRは最速と予測されます。
ポリメラーゼ連鎖反応（PCR）技術は、COVID-19、HIV、肝炎、結核を含む広範な感染症の検出に広く応用されているため、2024年に圧倒的な収益シェアを確保しました。
呼吸器疾患は、2024年に71.96%の最大市場シェアを占め、主に呼吸器合胞体ウイルス（RSV）、インフルエンザ、COVID-19などの呼吸器感染症の有病率の上昇によって牽引されました。
HIV、肝炎、結核、呼吸器感染症など、正確でタイムリーな診断を必要とする感染症の流行が高まっていることが背景にあります。
北米感染症分子診断市場は、COVID-19、インフルエンザ、HIV、肝炎などの感染症の高い流行によって牽引され、2024年の収益シェアの40.95％を占めました。

セグメントダッシュボード
感染症分子診断市場：技術変動分析、2024年と2030年
ポリメラーゼ連鎖反応（PCR）
- マルチプレックスPCR
- その他のPCR
in situ-ハイブリダイゼーション
- 機器
- 試薬
- その他
等温核酸増幅技術（INAAT）
- 機器
- 試薬
- その他
チップとマイクロアレイ
- 機器
- 試薬
- その他
質量分析
- 機器
- 試薬
- その他
シーケンス
- 機器
- 試薬
- その他
転写による増幅
- 機器
- 試薬
- その他
その他
- 機器
- 試薬
- その他

第6章感染症分子診断市場：用途別、推定・動向分析

セグメントダッシュボード
感染症分子診断市場：用途変動分析、2024年と2030年
呼吸器疾患
結核
髄膜炎
消化管感染症
HPV
性感染症
敗血症
薬剤耐性疾患
その他

第7章感染症分子診断市場：最終用途別、推定・動向分析

セグメントダッシュボード
感染症分子診断市場：最終用途変動分析、2024年と2030年
病院
クリニック
診断ラボ
研究機関

第8章感染症分子診断市場：地域別、推定・動向分析

感染症分子診断市場シェア、地域別、2024年と2030年
北米
- 米国
- カナダ
- メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- タイ
ラテンアメリカ
- ブラジル
- アルゼンチン
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

主要市場参入企業による最近の動向と影響分析
企業分類
企業ヒートマップ分析
企業プロファイル
- Abbott
- Danaher Corporation
- bioMerieux SA
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Hologic, Inc.（Gen-Probe）
- Grifols SA
- Qiagen
- Siemens Healthineers AG
- Sysmex Corporation

図表

List of Tables

Table 1 List of abbreviation
Table 2 Global infectious disease molecular diagnostics market, by region, 2018 - 2030 (USD Million)
Table 3 Global infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 4 Global infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 5 Global infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 6 Global infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 7 North America infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
Table 8 North America infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 9 North America infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 10 North America infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 11 North America infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 12 U.S. infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 13 U.S. infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 14 U.S. infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 16 Canada infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 17 Canada infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 18 Canada infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 19 Canada infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 20 Mexico infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 21 Mexico infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 22 Mexico infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 23 Mexico infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 24 Europe infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
Table 25 Europe infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 26 Europe infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 27 Europe infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 28 Europe infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 29 UK infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 30 UK infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 31 UK infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 32 UK infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 33 Germany infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 34 Germany infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 35 Germany infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 36 Germany infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 France infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 38 France infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 39 France infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 40 France infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 41 Italy infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 42 Italy infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 43 Italy infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 44 Italy infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 45 Spain infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 46 Spain infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 47 Spain infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 48 Spain infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 49 Denmark infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 50 Denmark infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 51 Denmark infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 52 Denmark infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 53 Sweden infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 54 Sweden infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 55 Sweden infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 56 Sweden infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 57 Norway infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 58 Norway infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 59 Norway infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 60 Norway infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 61 Asia Pacific infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
Table 62 Asia Pacific infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 63 Asia Pacific infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 64 Asia Pacific infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 65 Asia Pacific infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 66 Japan infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 67 Japan infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 68 Japan infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 69 Japan infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 70 China infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 71 China infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 72 China infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 73 China infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 74 India infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 75 India infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 76 India infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 77 India infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 78 Australia infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 79 Australia infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 80 Australia infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 81 Australia infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 82 South Korea infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 83 South Korea infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 84 South Korea infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 85 South Korea infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 86 Thailand infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 87 Thailand infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 88 Thailand infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 89 Thailand infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 90 Latin America infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
Table 91 Latin America infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 92 Latin America infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 93 Latin America infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 94 Latin America infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 95 Brazil infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 96 Brazil infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 97 Brazil infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 98 Brazil infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 99 Argentina infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 100 Argentina infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 101 Argentina infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 103 MEA infectious disease molecular diagnostics market, by country, 2018 - 2030 (USD Million)
Table 104 MEA infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 105 MEA infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 106 MEA infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 107 MEA infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 108 South Africa infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 109 South Africa infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 110 South Africa infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 116 UAE infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 117 UAE infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 118 UAE infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 119 UAE infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 120 Kuwait infectious disease molecular diagnostics market, by product, 2018 - 2030 (USD Million)
Table 121 Kuwait infectious disease molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 122 Kuwait infectious disease molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait infectious disease molecular diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Infectious disease molecular diagnostics market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter's five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Infectious disease molecular diagnostics market: Product outlook key takeaways
Fig. 20 Infectious disease molecular diagnostics market: Product movement analysis
Fig. 21 Transfemoral market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Infectious disease molecular diagnostics market: Technology outlook key takeaways
Fig. 26 Infectious disease molecular diagnostics market: Technology movement analysis
Fig. 27 Polymerase Chain Reaction (PCR) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 In Situ Hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Isothermal Nucleic Acid Amplification Technology (INAAT) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Chips and Microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Mass Spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Transcription Mediated Amplification market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Multiplex PCR market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Other PCR market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Infectious disease molecular diagnostics market: Application outlook key takeaways
Fig. 58 Infectious disease molecular diagnostics market: Application movement analysis
Fig. 59 Respiratory Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Tuberculosis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Meningitis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Gastrointestinal Tract Infections market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 HPV market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Sexually Transmitted Infections market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Sepsis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Drug Resistance Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Infectious disease molecular diagnostics market: End use outlook key takeaways
Fig. 69 Infectious disease molecular diagnostics market: End use movement analysis
Fig. 70 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Diagnostics Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Regional marketplace outlook, 2024 & 2030 (USD Million)
Fig. 75 Regional marketplace: Key takeaways
Fig. 76 North America infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 U.S. infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Canada infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Mexico infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Europe infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 UK infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Germany infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 France infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 Spain infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Italy infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Denmark infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 Sweden infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Norway infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Asia Pacific infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 Japan infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Key country dynamics
Fig. 104 China infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 India infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Australia infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 Key country dynamics
Fig. 110 South Korea infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 Key country dynamics
Fig. 112 Thailand infectious disease molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 113 Key country dynamics
Fig. 114 Market participant categorization
Fig. 115 Infectious disease molecular diagnostics market position analysis, 2023
Fig. 116 Strategic framework

Product Code: GVR-4-68039-529-7

Infectious Disease Molecular Diagnostics Market Growth & Trends:

The global infectious disease molecular diagnostics market size is expected to reach USD 20.15 billion by 2030, registering a CAGR of 3.37% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the introduction of technologically advanced products and an increase in demand for molecular diagnostics in PoC settings.

Rapid technological advancements with portability, accurate results, and cost-effectiveness are anticipated to serve as crucial drivers of the market for infectious disease molecular diagnostics. Companies are upgrading their products by implementing new techniques to gain specific and accurate results. Key players are updating their product portfolio for PCR instruments with increased R&D initiatives for developing novel kits to target emerging diseases or by entering into agreements with other kit manufacturing companies.

Technologies such as INAAT, mass spectroscopy, and ISH are advanced and have a low false-positive rate as compared to other traditional diagnostic tests. Advantages such as the cost-effectiveness and user-friendliness of this technology and the accuracy offered are estimated to increase the adoption of this technology.

The use of molecular diagnostics in research institutes is increasing. The use of techniques such as PCR, western blotting, and southern blotting is becoming common. Moreover, the spread of SARS-CoV-2 infection globally has led to an increase in research funding by governments as well as diagnostic companies to search for innovative molecular diagnostics.

Molecular diagnostics deliver effective and accurate results. Moreover, these tests enable the early detection of diseases, maintaining a low threat of substitutes. However, the high prices of these tests are expected to encourage patients to shift to external substitutes. Moreover, for the detection of newer infections such as SARS-CoV-2, the rate of internal substitution is high, which boosts competitive rivalry.

Infectious Disease Molecular Diagnostics Market Report Highlights:

Reagents led the market with a 25.86% revenue share in 2024 and are projected to experience the fastest CAGR over the forecast period due to their widespread use in infectious disease diagnostics.
Polymerase Chain Reaction (PCR) technology secured the dominant revenue share in 2024 owing to its widespread application in detecting a broad range of infectious diseases, including COVID-19, HIV, hepatitis, and tuberculosis.
Respiratory diseases held the largest market share of 71.96% in 2024, driven primarily by the rising prevalence of respiratory infectious diseases such as Respiratory Syncytial Virus (RSV), influenza, COVID-19, etc.
Diagnostic laboratories held the dominant revenue share in 2024, driven by the rising prevalence of infectious diseases such as HIV, hepatitis, tuberculosis, and respiratory infections, which require accurate and timely diagnosis.
North America infectious disease molecular diagnosis market accounted for 40.95% of the revenue share in 2024, driven by the high prevalence of infectious diseases such as COVID-19, influenza, HIV, and hepatitis.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Infectious Disease Molecular Diagnostics Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Infectious Disease Molecular Diagnostics Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Infectious Disease Molecular Diagnostics Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Infectious Disease Molecular Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million)
4.3. Instruments
- 4.3.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Reagents
- 4.4.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Services
- 4.5.1. Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Infectious Disease Molecular Diagnostics Market: Technology Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Infectious Disease Molecular Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million)
5.3. Polymerase Chain Reaction (PCR)
- 5.3.1. Polymerase Chain Reaction (PCR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2. Multiplex PCR
  - 5.3.2.1. Multiplex PCR Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 5.3.2.2. Instruments
    - 5.3.2.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 5.3.2.3. Reagents
    - 5.3.2.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 5.3.2.4. Others
    - 5.3.2.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.3. Other PCR
5.4. In Situ Hybridization
- 5.4.1. In Situ Hybridization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.2. Instruments
  - 5.4.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.3. Reagents
  - 5.4.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.4. Others
  - 5.4.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
- 5.5.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.2. Instruments
  - 5.5.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.3. Reagents
  - 5.5.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.4. Others
  - 5.5.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Chips and Microarrays
- 5.6.1. Chips and Microarrays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.2. Instruments
  - 5.6.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.3. Reagents
  - 5.6.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.4. Others
  - 5.6.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Mass Spectrometry
- 5.7.1. Mass Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.2. Instruments
  - 5.7.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.3. Reagents
  - 5.7.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.4. Others
  - 5.7.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Sequencing
- 5.8.1. Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8.2. Instruments
  - 5.8.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8.3. Reagents
  - 5.8.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8.4. Others
  - 5.8.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Transcription Mediated Amplification
- 5.9.1. Transcription Mediated Amplification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9.2. Instruments
  - 5.9.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9.3. Reagents
  - 5.9.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9.4. Others
  - 5.9.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Others
- 5.10.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.10.2. Instruments
  - 5.10.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.10.3. Reagents
  - 5.10.3.1. Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.10.4. Others
  - 5.10.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Infectious Disease Molecular Diagnostics Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Infectious Disease Molecular Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
6.3. Respiratory Diseases
- 6.3.1. Respiratory Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Tuberculosis
- 6.4.1. Tuberculosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Meningitis
- 6.5.1. Meningitis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Gastrointestinal Tract Infections
- 6.6.1. Gastrointestinal Tract Infections Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. HPV
- 6.7.1. HPV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Sexually Transmitted Infections
- 6.8.1. Sexually Transmitted Infections Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Sepsis
- 6.9.1. Sepsis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Drug Resistance Diseases
- 6.10.1. Drug Resistance Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.11. Others
- 6.11.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Infectious Disease Molecular Diagnostics Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Infectious Disease Molecular Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
7.3. Hospitals
- 7.3.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Clinics
- 7.4.1. Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Diagnostics Laboratories
- 7.5.1. Diagnostics Laboratories Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Research Institutes
- 7.6.1. Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Infectious Disease Molecular Diagnostics Market: Regional Estimates & Trend Analysis

8.1. Infectious Disease Molecular Diagnostics Market Share, By Region, 2024 & 2030 (USD Million)
8.2. North America
- 8.2.1. North America Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.2. U.S.
  - 8.2.2.1. U.S. Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.3. Canada
  - 8.2.3.1. Canada Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.4. Mexico
  - 8.2.4.1. Mexico Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
- 8.3.1. Europe Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. UK
  - 8.3.2.1. UK Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Germany
  - 8.3.3.1. Germany Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.4. France
  - 8.3.4.1. France Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.5. Italy
  - 8.3.5.1. Italy Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.6. Spain
  - 8.3.6.1. Spain Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.7. Denmark
  - 8.3.7.1. Denmark Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.8. Sweden
  - 8.3.8.1. Sweden Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.9. Norway
  - 8.3.9.1. Norway Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
- 8.4.1. Asia Pacific Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. Japan
  - 8.4.2.1. Japan Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. China
  - 8.4.3.1. China Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. India
  - 8.4.4.1. India Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. Australia
  - 8.4.5.1. Australia Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. South Korea
  - 8.4.6.1. South Korea Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Thailand
  - 8.4.7.1. Thailand Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
- 8.5.1. Latin America Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. Brazil
  - 8.5.2.1. Brazil Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Argentina
  - 8.5.3.1. Argentina Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
- 8.6.1. Middle East and Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. South Africa
  - 8.6.2.1. South Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Saudi Arabia
  - 8.6.3.1. South Africa Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. UAE
  - 8.6.4.1. UAE Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. Kuwait
  - 8.6.5.1. Kuwait Infectious Disease Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
- 9.4.1. Abbott
  - 9.4.1.1. Participant's Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Recent Developments/ Strategic Initiatives
- 9.4.2. Danaher Corporation
  - 9.4.2.1. Participant's Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Recent Developments/ Strategic Initiatives
- 9.4.3. bioMerieux SA
  - 9.4.3.1. Participant's Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Recent Developments/ Strategic Initiatives
- 9.4.4. F. Hoffmann-La Roche Ltd
  - 9.4.4.1. Participant's Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Recent Developments/ Strategic Initiatives
- 9.4.5. Bio-Rad Laboratories, Inc.
  - 9.4.5.1. Participant's Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Recent Developments/ Strategic Initiatives
- 9.4.6. Agilent Technologies, Inc.
  - 9.4.6.1. Participant's Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Recent Developments/ Strategic Initiatives
- 9.4.7. Becton, Dickinson and Company
  - 9.4.7.1. Participant's Overview
  - 9.4.7.2. Financial Performance
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Recent Developments/ Strategic Initiatives
- 9.4.8. Hologic, Inc. (Gen-Probe)
  - 9.4.8.1. Participant's Overview
  - 9.4.8.2. Financial Performance
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Recent Developments/ Strategic Initiatives
- 9.4.9. Grifols S.A.
  - 9.4.9.1. Participant's Overview
  - 9.4.9.2. Financial Performance
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Recent Developments/ Strategic Initiatives
- 9.4.10. Qiagen
  - 9.4.10.1. Participant's Overview
  - 9.4.10.2. Financial Performance
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Recent Developments/ Strategic Initiatives
- 9.4.11. Siemens Healthineers AG
  - 9.4.11.1. Participant's Overview
  - 9.4.11.2. Financial Performance
  - 9.4.11.3. Product Benchmarking
  - 9.4.11.4. Recent Developments/ Strategic Initiatives
- 9.4.12. Sysmex Corporation
  - 9.4.12.1. Participant's Overview
  - 9.4.12.2. Financial Performance
  - 9.4.12.3. Product Benchmarking
  - 9.4.12.4. Recent Developments/ Strategic Initiatives

感染症分子診断の市場規模、シェア、動向分析レポート：製品別、技術別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

感染症分子診断市場の成長と動向

感染症分子診断市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章感染症分子診断市場の変数、動向、範囲

第4章感染症分子診断市場：製品別、推定・動向分析

第5章感染症分子診断市場：技術別、推定・動向分析

第6章感染症分子診断市場：用途別、推定・動向分析

第7章感染症分子診断市場：最終用途別、推定・動向分析

第8章感染症分子診断市場：地域別、推定・動向分析

第9章競合情勢

List of Tables

List of Figures

Infectious Disease Molecular Diagnostics Market Growth & Trends:

Infectious Disease Molecular Diagnostics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Infectious Disease Molecular Diagnostics Market Variables, Trends, & Scope

Chapter 4. Infectious Disease Molecular Diagnostics Market: Product Estimates & Trend Analysis

Chapter 5. Infectious Disease Molecular Diagnostics Market: Technology Estimates & Trend Analysis

Chapter 6. Infectious Disease Molecular Diagnostics Market: Application Estimates & Trend Analysis

Chapter 7. Infectious Disease Molecular Diagnostics Market: End Use Estimates & Trend Analysis

Chapter 8. Infectious Disease Molecular Diagnostics Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

感染症分子診断の市場規模、シェア、動向分析レポート：製品別、技術別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

感染症分子診断市場の成長と動向

感染症分子診断市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 感染症分子診断市場の変数、動向、範囲

第4章 感染症分子診断市場：製品別、推定・動向分析

第5章 感染症分子診断市場：技術別、推定・動向分析

第6章 感染症分子診断市場：用途別、推定・動向分析

第7章 感染症分子診断市場：最終用途別、推定・動向分析

第8章 感染症分子診断市場：地域別、推定・動向分析

第9章 競合情勢

List of Tables

List of Figures

Infectious Disease Molecular Diagnostics Market Growth & Trends:

Infectious Disease Molecular Diagnostics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Infectious Disease Molecular Diagnostics Market Variables, Trends, & Scope

Chapter 4. Infectious Disease Molecular Diagnostics Market: Product Estimates & Trend Analysis

Chapter 5. Infectious Disease Molecular Diagnostics Market: Technology Estimates & Trend Analysis

Chapter 6. Infectious Disease Molecular Diagnostics Market: Application Estimates & Trend Analysis

Chapter 7. Infectious Disease Molecular Diagnostics Market: End Use Estimates & Trend Analysis

Chapter 8. Infectious Disease Molecular Diagnostics Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章感染症分子診断市場の変数、動向、範囲

第4章感染症分子診断市場：製品別、推定・動向分析

第5章感染症分子診断市場：技術別、推定・動向分析

第6章感染症分子診断市場：用途別、推定・動向分析

第7章感染症分子診断市場：最終用途別、推定・動向分析

第8章感染症分子診断市場：地域別、推定・動向分析

第9章競合情勢